12:49 May 18
Glenmark Life Sciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Glenmark Life Sciences Ltd.
Industry Pharmaceuticals
12:49 May 18
Quality
52/100
Medium Financial Strength
Valuation
39/100
Mid Valuation
Technical
60/100
Technically Neutral
Strength
6
Weakness
3
Opportunity
1
Threats
1
2.74 %
Dividend Yield
10.08K
Market Cap (Cr)
51.64
RSI
82.85 %
Promoter Holding
0.00 %
Net Profit Margin
| Ex-Date | Type | Description | Record Date | Ratio | Dividend Type |
|---|---|---|---|---|---|
| 17-Oct-2023 | Dividend | 22.50/share@1,125.00% | 17-Oct-2023 | 1,125.00 | Interim |
| 24-Mar-2023 | Dividend | 21.00/share@1,050.00% | 24-Mar-2023 | 1,050.00 | Interim |
| 15-Sep-2022 | Dividend | 10.50/share@525.00% | - | 525.00 | Final |
| 22-Nov-2021 | Dividend | 10.50/share@525.00% | 23-Nov-2021 | 525.00 | Interim |
Download Our App On:
